Abionyx Pharma (CHIX:ABNXP) FCF Yield %: -3.61 (As of Jul. 02, 2026)


CHIX:ABNXP Abionyx Pharma CHIX:ABNXP
15 GF Score
Price €1.73
GF Value €0.70
! 4 Warning Signs
View Full Analysis

What is Abionyx Pharma FCF Yield %?

Abionyx Pharma CHIX:ABNXP 15 FCF Yield % is -3.61 as of Jul. 02, 2026. GuruFocus rates CHIX:ABNXP with a GF Score™ of 15/100 and a GF Value™ of €0.70. The stock has 4 warning signs investors should review. Among 1,414 Biotechnology companies, Abionyx Pharma ranks better than 68.25% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Abionyx Pharma's Trailing 12-Month Free Cash Flow is €-3.18 Mil, and Market Cap is €88.01 Mil. Therefore, Abionyx Pharma's FCF Yield % for today is -3.61%.

The historical rank and industry rank for Abionyx Pharma's FCF Yield % or its related term are showing as below:

CHIX:ABNXp' s FCF Yield % Range Over the Past 10 Years
Min: -149.74   Med: -12.81   Max: -2.03
Current: -3.61


During the past 13 years, the highest FCF Yield % of Abionyx Pharma was -2.03%. The lowest was -149.74%. And the median was -12.81%.

CHIX:ABNXp's FCF Yield % is ranked better than
68.25% of 1414 companies
in the Biotechnology industry
Industry Median: -9.525 vs CHIX:ABNXp: -3.61

Abionyx Pharma's FCF Margin % for the quarter that ended in Dec. 2025 was -67.75%.


Abionyx Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Abionyx Pharma FCF Yield % Related Terms


Abionyx Pharma FCF Yield % Historical Data

* Premium members only.

The historical data trend for Abionyx Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abionyx Pharma FCF Yield % Chart

Abionyx Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.03 -7.15 -6.76 -6.09 -5.12

Abionyx Pharma Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.30 -6.72 -5.94 -6.11 -4.24

CHIX:ABNXP vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Abionyx Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abionyx Pharma FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abionyx Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Abionyx Pharma's FCF Yield % falls into.


CHIX:ABNXP
15GF Score
Abionyx Pharma CHIX:ABNXP
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abionyx Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Abionyx Pharma's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-3.175 / 62.067952
=-5.12%

Abionyx Pharma's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.317 * 2 / 62.067952
=-4.24%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -3.61 mean?
Abionyx Pharma (CHIX:ABNXP) has a FCF Yield % of -3.61 as of Jul. 02, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Abionyx Pharma and its competitors. According to the industry distribution chart, Abionyx Pharma ranks #449 out of 1414 companies in the Biotechnology industry, placing it in the top 31.8%.
Is Abionyx Pharma's FCF Yield % too high?
Abionyx Pharma's current FCF Yield % is -3.61. Based on the distribution chart, Abionyx Pharma ranks #449 out of 1414 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Abionyx Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Abionyx Pharma's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Abionyx Pharma ranks #449 out of 1414 companies for FCF Yield %. This puts Abionyx Pharma in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Abionyx Pharma and its competitors. Abionyx Pharma's current FCF Yield % is -3.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abionyx Pharma stock overvalued right now?
Abionyx Pharma (CHIX:ABNXP) has a current FCF Yield % of -3.61. The stock's GF Value™ is €0.70, compared to a current price of €1.73 — trading 147.4% above its estimated fair value. The current FCF Yield % is -3.61. Abionyx Pharma's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Abionyx Pharma (CHIX:ABNXP), the current FCF Yield % is -3.61 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abionyx Pharma (CHIX:ABNXP) Overvalued in 2026?

Based on GuruFocus' analysis, Abionyx Pharma stock appears to be overvalued. The current stock price of €1.73 is trading 147.4% above its estimated GF Value™ of €0.70.

Key valuation signals for CHIX:ABNXP:

  • FCF Yield %: -3.61
  • GF Value™: €0.70 vs. price of €1.73 (147.4% above fair value)
  • GF Score™: 15/100 with 4 warning signs

No single metric tells the full story. See the CHIX:ABNXP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abionyx Pharma Business Description

Address 33-43 Avenue Georges Pompidou-Bat D2, Balma, FRA, 31130
Abionyx Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. The biotech assets inherited from CERENIS Therapeutics constitute a portfolio of valuable programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as an HDL targeted drug delivery platform in oncology, more specifically in Immuno oncology and chemotherapy.
15GF Score

Get the complete analysis for CHIX:ABNXP

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.73
Price
€0.70
GF Value